Cancer cure with organ preservation using radiation therapy.
In 1985, the American Cancer Society has anticipated that 910,000 new cases of invasive cancer will be diagnosed in the United States. More than 37% of those patients can be treated for cure with organ preservation using radiation therapy. The basic biologic background for such an approach to the problem is well established. Clinical data to substantiate the validity of the concept date from 1902 to the present. Without question, organ preservation is becoming a major and important concept in the management of the patient with cancer, and new and innovative techniques for treatment are enabling the organ to be preserved, the cancer to be cured, and appropriate cosmesis and function to be preserved. Many tumor sites are appropriate for this treatment technique, including the breast, the eye, the larynx, and the prostate. In 1985, there has been new emphasis on the successful treatment of cancer with the preservation of the organ intact. The maxim to offer the patient the maximum potential for cure with the minimum complication now has an additional concept related to the opportunity to preserve cosmesis and function.
D001943:Breast Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D002830:Choroid Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000532:radiotherapy*; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011878:Radiotherapy / Q000379:methods / Q000639:trends; D014481:United States